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The dose-dependent toxicity of the main psychoactive component of cannabis in brain regions rich in cannabinoid CB1 receptors is well
known in animal studies. However, research in humans does not show common findings across studies regarding the brain regions that are
affected after long-term exposure to cannabis. In the present study, we investigate (using Voxel-based Morphometry) gray matter changes in
a group of regular cannabis smokers in comparison with a group of occasional smokers matched by the years of cannabis use. We provide
evidence that regular cannabis use is associated with gray matter volume reduction in the medial temporal cortex, temporal pole,
parahippocampal gyrus, insula, and orbitofrontal cortex; these regions are rich in cannabinoid CB1 receptors and functionally associated with
motivational, emotional, and affective processing. Furthermore, these changes correlate with the frequency of cannabis use in the 3 months
before inclusion in the study. The age of onset of drug use also influences the magnitude of these changes. Significant gray matter volume
reduction could result either from heavy consumption unrelated to the age of onset or instead from recreational cannabis use initiated at an
adolescent age. In contrast, the larger gray matter volume detected in the cerebellum of regular smokers without any correlation with the
monthly consumption of cannabis may be related to developmental (ontogenic) processes that occur in adolescence.
Neuropsychopharmacology (2014) 39, 2041–2048; doi:10.1038/npp.2014.67; published online 16 April 2014
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INTRODUCTION
Cannabis is one of the most widely used recreational drugs,
taking third place among drugs of concern in addiction
treatment services (Degenhardt et al, 2008). Despite these
statistics pointing to the potential harms associated with long-
term cannabis use, little is known about the progression from
recreational to regular use and its effects on brain structure.
Current knowledge is mostly inferred from animal
studies; it has been demonstrated that the main psycho-
active component of cannabis (D9-Tetrahydrocannabinol,
THC) induces dose-dependent toxicity and structural
changes in brain regions rich in cannabinoid CB1 receptors.
These are mainly located in the hippocampus, amygdala,
cerebellum, prefrontal cortex, and striatum (Burns et al,
2007; Downer et al, 2001; Lawston et al, 2000).
In contrast to the animal literature, the investigation of
the structural effects of long-term cannabis use on the
human brain has brought less consistent findings. Changes
in gray or white matter density have been reported in
different locations in frontal and parietal lobes without
overlapping findings across studies (Churchwell et al, 2010;
Gruber et al, 2011; Matochik et al, 2005). The discrepancy
in the results might be due to heterogeneity in sample
characteristics, inter-individual differences linked to past
history of drug use, amount of consumption, related
psychological problems (temperament, level of anxiety or
arousal), and/or methodological differences in data proces-
sing (Batalla et al, 2013; Lorenzetti et al, 2010). However,
changes in the hippocampus/parahippocampal complex and
in the amygdala have often been reported (Demirakca et al,
2011; Matochik et al, 2005; Yu¨cel et al, 2008; Zalesky et al,
2012). These findings suggest that long-term cannabis use is
associated with brain morphology alterations in regions
linked to memory and executive and affective processing
(Yu¨cel et al, 2008).
Decrease in hippocampal volume in regular cannabis
smokers has been correlated with lifetime consumption
(Ashtari et al, 2011; Yu¨cel et al, 2008) and psychotic
symptoms (Yu¨cel et al, 2008). In Cousijn et al (2012),
volume reduction in the amygdala and the hippocampus
does not differ significantly between regular cannabis users
and controls but still correlates with the amount of cannabis
used and the severity of cannabis dependence, respectively.
In addition to the several issues characterizing the
literature so far, most of the studies examine only
predefined regions of interest (i.e., the hippocampus and
*Correspondence: Professor P Maeder, Department of Radiology,
CHUV, Rue du Bugnon 46, Lausanne CH-1011, Switzerland, Tel:
+41 795561684, Fax: +41 213144554,
E-mail: Philippe.Maeder@chuv.ch
8These authors contributed equally to this work.
Received 5 December 2013; revised 22 February 2014; accepted 6
March 2014; accepted article preview online 17 March 2014
Neuropsychopharmacology (2014) 39, 2041–2048
& 2014 American College of Neuropsychopharmacology. All rights reserved 0893-133X/14
www.neuropsychopharmacology.org
amygdala because of their richness in CB1 receptors),
making it difficult to draw consistent and complete
conclusions about the long-term effects of cannabis use
on brain structure.
Another question of interest is whether cannabis use is
associated with differential effects on brain structure
according to the age of consumption onset; more specifi-
cally, does the use of cannabis during adolescence lead to
the same changes in brain structure as initial exposure later
in life? Adolescence is an important period in brain
development when proper structural maturation of fiber
tracts occurs (necessary for the development of cognitive,
motor, and sensory functions) (Paus et al, 1999). Environ-
mental factors, such as drug use, can alter the maturational
arrangements that normally occur in the adolescent brain
(Hurd et al, 2013), increasing the incidence of psychiatric
illness and substance abuse (Paus et al, 2008). The study by
Zalesky et al (2012) shows a linear correlation between
measures of white matter (WM) integrity and the age of
onset of regular cannabis use, thus suggesting a toxic effect
of long-term cannabis use to WM development.
In our study, we investigate the precise nature of structural
changes induced by cannabis and try to answer three main
questions: (i) Can we observe temporal and frontal (includ-
ing insular) gray matter changes after long-term exposure
to cannabis? (ii) Is the magnitude of these changes related to
the amount of cannabis consumed? (iii) Are these changes
influenced by the age of first use (during/after adolescence)?
Unlike many previous studies, we used a whole-brain
voxel-wise approach in order to localize gray matter change
due to long-term exposure to cannabis. To this end, we used
Voxel-based Morphometry (VBM), a completely automatic
and unbiased data processing technique for the assessment
of gray matter density. This technique has been already
widely used in clinical research (Draganski and Bhatia,
2010) and in drug addiction (Connolly et al, 2013).
Brain structure changes were investigated in a group of
regular cannabis smokers and compared with a group of
occasional smokers enrolled in our previous functional
study (Battistella et al, 2013). The subjects in the two groups
did not use any drug other than cannabis and were free
from psychiatric disorders. We then stratified the two
groups according to the age of first cannabis use in order to
assess the effect of cannabis on the developing brain.
MATERIALS AND METHODS
The present study is a part of a Magnetic Resonance
Imaging (MRI) study with the aim of investigating (at the
functional and structural levels) the acute and chronic
effects of cannabis smoking on specific skills related to
driving ability (Battistella et al, 2013). The study was
conducted according to Good Clinical Practice and ICH
requirements and has been approved by the local Ethics
Committee of the Canton de Vaud (Lausanne) Switzerland.
Subjects and Recruitment
Thirty-one healthy male occasional cannabis smokers
between 18 and 30 years of age and twenty-six male regular
cannabis users participated in the study. Subjects were
recruited through public advertisements at universities. The
mean consumption of cannabis for the 3 months preceding
inclusion in the study was set to a minimum of one joint per
month and a maximum of less than one joint per week
for the occasional smokers, and to a minimum of 10 joints
per month for regular ones (Fabritius et al, 2013a). All
volunteers had no history of neurological or psychiatric
disorders. Nine occasional and one regular users were
excluded from the research protocol for different reasons
(claustrophobia, detection of brain anomalies, decision to
drop out of the study, or technical problems during data
processing). The final population selected for this study
consists of 22 occasional cannabis smokers (median age
25 years, SD 2.8 years) and 25 regular users (median age
23 years, SD 2.2 years).
All participants were carefully screened with an interview
and a medical evaluation to ensure that they fulfilled all
study criteria. Further details regarding the inclusion
procedure are indicated in Battistella et al (2013). In both
groups of cannabis users, we performed a urine and a blood
test during the inclusion process in order to determine the
concentration of D9-Tetrahydrocannabinol-carboxylic acid
(THCCOOH) and confirm the regular use and the extent of
cannabis consumption (Fabritius et al, 2013b). Participants
also filled out a questionnaire about their usual drug use
habits. Cannabinoid time profiles in whole blood were
determined with the analytical procedures described by
Fabritius et al (2013a). Presence of other illicit drugs
(cocaine, opiates, and amphetamines) and a positive breath
alcohol test were also considered as exclusion criteria.
Major characteristics of the population are shown in
Table 1; for each variable of interest, we tested the null
hypothesis of whether the data followed a normal distribu-
tion using the Shapiro-Wilk test. As the null hypothesis was
rejected, we performed group comparisons by the mean of
the non-parametric Wilcoxon-signed ranks test.
MRI Acquisition Protocol
Scanning was performed on a 3T Siemens Trio scanner
equipped with a 32-channel head coil. The protocol inclu-
ded a high-resolution sagittal T1-weighted 3D gradient-echo
sequence (MPRAGE), 160 contiguous slices, 1mm iso-
tropic voxel, repetition time (TR) 2300ms, echo time (TE)
2.98ms, field of view 256mm. We prevented head move-
ments by cushioning the participant’s head in the coil with
padding.
MRI Data Processing
MRI data were pre-processed and analyzed using Statistical
Parametric Mapping (SPM8, Wellcome Department of
Cognitive Neurology, London, UK). For Voxel-Based
morphometry (VBM) analysis, T1-weighted data were
classified as gray matter, white matter (WM), and
cerebrospinal fluid (CSF) using the unified segmentation
approach (Ashburner and Friston, 2005). In order to
improve registration accuracy, images were non-linearly
transformed to the standard Montreal Neurological Institute
(MNI) space using the diffeomorphic registration algorithm
(DARTEL) (Ashburner, 2007). After registration and
bias correction, GM probability maps were subsequently
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‘modulated’ by the Jacobian determinants of the deforma-
tions to account for local compression and expansion
during linear and non-linear transformation (Good et al,
2001). Finally, GM probability maps were smoothed with an
isotropic Gaussian kernel of 6mm full width at half
maximum (FWHM) to improve Signal-to-Noise Ratio
(SNR) and to conform the data more closely to a Gaussian
distribution for statistics. Voxel-based inferential statistics
were performed on the smoothed modulated gray matter
images using a two-sample t-test embedded in the Random
Effect framework of SPM8. We included age, total brain
volume (TBV, the sum of gray matter and white matter),
and alcohol consumption as regressors of no interest to
control for the effects of these variables. Statistical thresh-
olds were applied at po0.05 after family-wise error (FWE)
correction for multiple comparisons over the whole brain
and k460 for cluster extent (greater than the minimum
voxels expected per cluster). Voxel-by-voxel correlation
analysis was performed between the smoothed modulated
gray matter images and the variable representative of the
level of drug use (monthly frequency of joints used in the 3
months before inclusion in the study) after testing the
presence of outliers.
Then, each group (occasional/regular) was stratified
according to the age of first use (before/after 18 years of
age) in order to assess whether the age at which cannabis
use started influences the magnitude of the decreased gray
matter volume localized with the two-sample t-test. The
four subgroups were composed of 13 occasional smokers
who started cannabis consumption before the age of 18
(called here ‘Occasional early’), and 9 who started after
(called ‘Occasional late’); 16 regular users who started
cannabis consumption before the age of 18 (called here
‘Regular early’), and 9 who started after (called ‘Regular
late’). Gray matter volume, represented by the value of
the modulated GM image, was compared between the
so-defined subgroups. We tested significant differences
between the ‘Occasional late’ group and all of the other
groups (ie, three tests for each region) at a level of po0.05
(corrected for multiple comparisons). For each comparison
between subgroups, we also computed the effect size (d) by
dividing the difference between mean values by the
common SD of the two groups (Cohen, 1988).
RESULTS
Self-rating questionnaires show a significant difference in
the frequency and amount of cannabis consumption
between the groups of regular and occasional smokers.
However, they do not differ in age, in the years of cannabis
use and or in the age at which consumption started
(Table 1). The median value of the self-reported usual
amount of cannabis smoked by regular users is higher than
that of occasional consumers (0.4 g vs 0.3 g). The determi-
nation of cannabinoid time profiles revealed that the
THCCOOH median level was significantly higher in regular
smokers compared with occasional users (21 mg/l vs 0 mg/l
just before smoking the joint). An equal difference was
found for the participants enrolled in the same study and
selected by Fabritius et al, (2013a) for the pharmacokinetic
determinations.
MRI Results
When comparing gray matter volume between groups, we
find that significant clusters showing a lower gray matter
volume in regular cannabis users compared with occasional
ones are located bilaterally in the temporal pole and in
the parahippocampal gyrus. Additional clusters cover the
left insula and the left orbitofrontal cortex (Figure 1).
In contrast, three cerebellar clusters show the opposite
behavior, with increased gray matter volume. Coordinates
of the centers of gravity of the significant clusters are
reported in the Montreal Neurological Institute (MNI) space
and are summarized in Tables 2 and 3.
Voxel-by-voxel correlations over the whole brain were
performed merging the two groups together. Correlation
analysis highlights an inverse linear correlation between GM
volume and the monthly frequency of cannabis use during
the 3 months before inclusion in the study. Regions with a
decreased GM volume in regular smokers (Table 2) are
Table 1 Descriptive Statistics of the Subjects Enrolled in the Study
Occasional Regular p-value
Median MAD Range Median MAD Range
Age 25 2 19–29 23 1.5 20–28 0.06
Education (post-compulsory, years) 6 2 4–9 6 2 2–15 0.9
Frequency of use last week (times/day) 0.14 0.1 0–1 2.5 0.5 1–7 o10 5
Frequency of use last 3 weeks (times/week) 1 0.63 0–2.5 20 5.5 5–60 o10 5
Frequency of use last 3 months (times/month) 3.5 1.5 1–10 62.5 22.5 20–250 o10 5
Years of usage 7.5 2.5 3.5–15 6.5 2.5 2–13 0.13
Age at onset 17 2 9–22.5 15.5 1.7 12–20 0.8
Alcohol (drinks/week) 5 2 1–10 10 5 0–80a 0.02
We report median values, median absolute deviation (MAD), range and significance of the between groups’ comparison by mean of Wilcoxon-signed rank test. The
years of usage and the age of onset refer to any cannabis use, and the alcohol consumption refers to drinks of 10 g ethanol.
aOnly one subject declared a weekly alcohol consumption of 80 drinks/week (outlier), all the other subjects ranged between 0 and 20.
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those that exhibit this inverse correlation (Po0.005). Figure 2
(panel a) illustrates this relation in three clusters located
in the left parahippocampal gyrus (P¼ 0.004, R¼  0.42),
left insula (P¼ 0.0002, R¼  0.54), and right temporal pole
(P¼ 0.002, R¼  0.45). The results for the other four regions
are presented in the Supplementary File S1.
The stratification of the two groups according to the age
of first cannabis use in the same clusters shows that a
decrease in gray matter volume can occur with a heavy
amount of cannabis consumption, independent of the years
of usage (Figure 2, panel b). The comparison between the
‘Occasional late’ subgroup and both the ‘Regular’ subgroups
shows a significant difference at Po0.05 in each cluster of
interest. Recreational consumption begun early in adoles-
cence (ie, ‘Occasional early’ subgroup) significantly affects
the GM volume in two regions out of three. These are
located in left parahippocampal gyrus (P=0.04) and right
temporal pole (P¼ 0.04); the left insula shows only a trend
Figure 1 Voxel-Based Morphometry results on gray matter. Cold color bar shows regions where gray matter volume is lower in regular smokers
compared with occasional ones. Hot color bar represents the opposite contrast. Maps are thresholded at Po0.005 and k460 and superposed on a
standard brain in the MNI space. Figure shows results in planes centered at  26, 7, 14mm and  48, 10,  19mm. Color bars represent T score.
Table 2 Local Maxima of Significant Clusters Showing Decreased Gray Matter Volume in Regular Cannabis Smokers
Region Left hemisphere MNI
coordinates (mm)
T-value Cluster extent Right hemisphere MNI
coordinates (mm)
T-value Cluster extent
x y z x y z
Superior orbital gyrus  22 14  14 5.15
Temporal pole  50 10  14 5.14 50 14  20 3.59 213a
Middle temporal gyrus  56 2  28 4.84 1215 64  10  20 4.36 271
Medial temporal pole  48 10  32 4.52 46 14  34 3.94 213a
Insula lobe  36 8  10 4.22
Parahippocampal gyrus  26 10  42 3.98 130 24 6  36 3.62 64
Precuneus 12  54 16 3.83 85
aBelong to the same cluster.
Table 3 Local Maxima of Significant Clusters Showing Increased Gray Matter Volume in Regular Cannabis Smokers
Region Left hemisphere MNI
coordinates (mm)
T-value Cluster extent Right hemisphere MNI
coordinates (mm)
T-value Cluster extent
x y z x y z
Lobule VIIa Crus I  48  54  28 4.27 431 30  86  22 4.56 562
Lobule VI  14  54  12 4 534
Vermis (VIII–IX)  10  56  36 3.55 74 8  62  36 3.5 117
Lobule I–IV 10  36  14 3.39 69
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at P¼ 0.09. The effect size measured by Cohen’s d was large
(d41) in each significant comparison. The results for the
other four regions are presented in the Supplementary File S1.
DISCUSSION
Our study demonstrates a pattern of gray matter volume
changes in a group of regular cannabis users compared with
a group of occasional ones. Regular users exhibit a decrease
in gray matter (GM) volume in the medial temporal cortex,
temporal pole, parahippocampal gyrus, left insula, and
orbitofrontal cortex. These changes strongly correlate with
the monthly frequency of cannabis use in the 3 months
before inclusion in the study. We chose the preceding
3-month period as the period of interest because the
participants’ cannabis use during this length of time is
representative of their usual cannabis use. Three clusters in
the cerebellum show the opposite behavior, with increased
GM volume. We also show that the age of onset of cannabis
use is correlated with the magnitude of gray matter volume
reduction in the cerebral hemispheres. Specifically, signi-
ficant gray matter atrophy can occur either with a heavy
cannabis consumption independent of the age of first use
or with recreational consumption that started during
adolescence (before the age of 18).
Our finding corroborates several animal studies (Burns
et al, 2007; Downer et al, 2001; Lawston et al, 2000), adding
evidence that the duration of exposure to cannabis is indeed
associated with localized volume reduction in regions rich in
CB1 receptors, correlating with the amount of cannabis used.
The progression of a long-term exposure to drugs toward
the development of substance use disorders and addicted
behaviors is often associated with deficits in decision
making (Koob and Volkow, 2010; Wiers et al, 2007). FMRI
demonstrates altered brain activity in core regions linked to
the motivational and affective aspects of decision making
(Cousijn et al, 2012; Vaidya et al, 2012), mainly in the
ventromedial prefrontal (VMPFC) and orbitofrontal cor-
tices and insula. In this regard, it has been demonstrated
that substance-dependent individuals and patients with
VMPFC lesions exhibit similar behaviors that lead them to
make similar decisions in real life, preferring choices that
bring immediate benefits even if coupled with negative
consequences (Bechara and Damasio, 2002).
In our study, we complement the functional evidence of
altered activity in nodes related to decision making by
showing in regular cannabis users a decrease in gray matter
volume in the insula, orbitofrontal cortex, and precuneus,
regions that are part of the motivational and affective
components of this network.
This observation supports and extends the conclusions
about compromised activity in the Salience Network nodes
(Seeley et al, 2007) described in occasional cannabis users
following the smoking of a single joint of cannabis
Figure 2 (a) Correlation between the modulated gray matter intensity at the center of gravity of the significant clusters and the monthly frequency of
joints smoked during 3 months before inclusion in the study. Lines represent the fitting of the distribution of the values. Pearson’s correlation coefficient and
P-value are shown at the bottom of each plot. (b) Mean GM volume across the four subgroups (Occasional late, Occasional early, Regular late, Regular
early). Whiskers represent 95% confidence interval, horizontal lines represent significant comparisons and stars the significance level (Po0.05).
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(Battistella et al, 2013). The key role in this network is
played by the insula, a region involved in subjects’
awareness of error, in the processing of affective and
internal information and in switching between the different
brain networks. Changes in this structure have also been
confirmed in alcohol addiction where the decrease in
insular activation seems to reflect an inability to switch
from interoceptive cravings to cognitive control for
suppressing internal needs (Sullivan et al, 2013). Here we
complement this finding of functional change with its
structural substrate. On the other hand, the activity in other
nodes of the Salience and the Control Executive networks
(VMPFC, ACC, Dorsolateral Prefrontal cortex) that is
compromised in occasional smokers is not associated with
structural changes in these regions in regular cannabis
smokers. It remains thus to be explored whether morpho-
logical variations in these areas may occur at a later stage or
in the presence of more serious addiction-related behaviors
that our participants do not exhibit.
In relation to gray matter volume reduction in regions
linked to affective and emotional processes described so far
(the insula and the orbitofrontal cortex), we also show
structural variations in the temporal pole (TP). The TP shares
cytoarchitectural and functional characteristics with the
orbitofrontal cortex (Kling and Steklis, 1976) and receives
projections from the insula. The volume reduction in these
regions observed in our population supports the idea of a
joint role of these structures in regular cannabis use. Evidence
exists about the role of the temporal pole (TP) in coupling
emotions and highly processed sensory stimuli (Olson et al,
2007). Lesions in this structure lead to changes in personality
and in social behavior (Thompson et al, 2003). Ablation of the
monkey orbitofrontal cortex, TP, and amygdala causes similar
socioemotional deficits. To our knowledge, ours is the first
study showing gray matter atrophy in the temporal pole in
regular cannabis users and the degree of atrophy related to
the frequency of drug use in the 3 months preceding inclusion
in the study. Previous research using ROI analysis did not
focus on possible changes in this region. With regard to the
two studies using VBM, one (Matochik et al, 2005) found
changes only in the medial part of the temporal cortex, maybe
due to the small sample studied; the other (Cousijn et al,
2012) failed to find any change in the cerebral cortex. Atrophy
of this structure has been found in cocaine users (Albein-
Urios et al, 2013) and has been linked to socioemotional and
personality problems.
In addition to the changes in the polar regions, there are
also changes in the medial temporal cortex, which is one of
the structures often reported to be associated with cannabis
addiction and where we find a strong bilateral decrease in
gray matter volume in the population of regular cannabis
users. Such a pattern of atrophy has been also described in
other forms of addiction such as alcohol addiction
(Mechtcheriakov et al, 2007), but not in heroin users
(Denier et al, 2013). However, other patients with severe,
non-toxic, behavioral addiction such as pathological
gambling (Levine et al, 2005) do not present the same form
of atrophy, suggesting that temporal atrophy is indeed
associated with cannabis consumption rather than with
addictive behavior itself. Despite the fact that the neuro-
biological interpretation of this volume reduction is still
unclear, studies on rodents give some clues on this point.
Scallet et al (1987) found a THC-induced decrease in the
mean volume of hippocampal neurons and a 44% reduction
in the number of synapses up to 7 months after exposure.
Functional and structural variations in the hippocampus
have been linked to reduced memory performance (Solowij
and Battisti, 2008) and psychotic symptoms (Yu¨cel et al,
2008). Cannabis exposure produces reduced activation in
the hippocampus during verbal and visual learning tasks
(Block et al, 2002; Jager et al, 2007).
Another main finding of our study is the increase in gray
matter volume in the cerebellum that replicates results in
adults (Cousijn et al, 2012) and in adolescents (Medina et al,
2010).
In normal adolescents the volume of cerebellar gray
matter starts to decrease around puberty and continues
until early adulthood (Diamond, 2000; Ostby et al, 2009).
Alterations of this phenomenon have been observed in
various psychiatric conditions (Mackie et al, 2007) (Jarvis
et al, 2008) (Castellanos et al, 2002) (Pujol et al, 2004)
(Hill et al, 2003) and in adolescents with familiar history
of severe alcohol abuse (Hill et al, 2007).
It has been hypothesized that this normal reduction in gray
matter volume in the cerebellum is due to the pruning of the
synaptic connections (Cohen-Cory, 2002). One possible reason
for abnormal pruning could be the toxic effect of THC at a
critical period of brain maturation. Endogenous cannabinoids
have an important role in synaptic pruning due to their
interaction with GB1 receptors controlling the release of
glutamate and GABA (Bossong and Niesink, 2010). Exogenous
cannabinoids might disturb this system by competing for the
receptors, thus inhibiting the pruning particularly in receptor-
rich areas like the cerebellum (Casu et al, 2005) or the
prefrontal cortex (Bossong and Niesink, 2010).
However, our results cannot exclude that abnormal
pruning is due to genetic predisposition as seen in children
from multiplex alcoholic families even before the beginning
of any drinking behavior or in obsessive compulsive
disorder (Hill et al, 2007). Hence, a limitation of our study
and a matter of debate in the literature are connected to the
question of whether these brain changes are caused by
cannabis use or are already present before drug use.
Additional limitation of our study is the relatively narrow
age-range of our participants (19–29 years of age) that may
limit the possibility to totally capture the cumulative effects
of cannabis. On the other hand, a 10-year window of age
range assures the homogeneity of the two groups, aspect of
paramount importance in the context of group analysis.
Existing literature shows that cognitive alterations and
CB1 receptor downregulation in regular cannabis users may
return to normal values due to neuroadaptive phenomena
occurring after periods of abstinence (Bosker et al, 2013;
Hanson et al, 2010; Hirvonen et al, 2012; Schweinsburg
et al, 2010). The design of our study cannot address whether
the structural alterations observed are permanent or
reversible. The so far unexplored evolution of the gray
matter alterations across time and the possible recovery
after recency of use should be addressed by further
longitudinal studies.
In our study, we provide new arguments about the effects of
long-term exposure to cannabis on brain structure integrity.
We were able to support all the hypotheses raised in the
introduction: (i) we demonstrate that regular cannabis use is
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associated with reduced gray matter volume in regions rich in
cannabinoid CB1 receptors that are functionally linked to
motivational, emotional, and affective processing. (ii) We
complete our findings by showing that the magnitude of
changes in these regions correlates with the frequency of
cannabis use and (iii) is modulated by the age at which
consumption was initiated.
We present a different scenario in the cerebellum where the
increase in gray matter volume in regular users without any
correlation with the amount of cannabis use may have a
developmental nature. The line of research should move
toward longitudinal studies in order to differentiate between
consumption-related and developmental aspects of brain
changes associated with long-term regular cannabis exposure.
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